ライフサイエンスコーパス: riboside

1 nicotinamide mononucleotide to nicotinamide riboside.

2 rylase has little activity on nicotinic acid riboside.

3 ivator 5-aminoimidazole-4-carboxamide-1-beta-riboside.

4 and its metabolite, imidazole-4-acetic acid-riboside.

5 high levels of the O-glucoside of cis-zeatin riboside.

6 4-tetrahydroisoquinoline with 6-chloropurine riboside.

7 agent, 5-aminoimidazole-4-carboxamide (AICA) riboside.

8 O2-methyluridine or 2-pyrimidinone-1-beta-d-riboside.

9 lymerase inhibitor 5,6-dichlorobenzimidazole riboside.

10 ible on resupplying NAD(+) with nicotinamide riboside.

11 n period and the use of the cytokinin zeatin riboside.

12 n be converted into analogues of carbocyclic ribosides.

13 n hydrolyze plant hormones such as cytokinin ribosides.

14 , human and mouse A(3)) better than that for ribosides.

15 with a tight-binding inhibitor, diazepinone riboside 1.

16 s precursor viral DNA was sensitive to the L-riboside 1263W94 [5, 6-dichloro-2-(isopropylamino)-1-bet

17 fluorescent probe, 2-aminopurine-2'-O-methyl riboside (2-AP) has been selectively incorporated at ade

18 -isopropylidenetiazofurin (20) or -benzamide riboside (21) followed by hydrolysis and deprotection af

19 >/=90% de and >99% ee) were converted into C-ribosides 29a,b via the Ru-catalyzed ring-closing metath

20 The pure diastereoisomer of known riboside 4 displayed high hA(1)AR selectivity.

21 The discovery that a 1,3-diazepinone riboside (4) operated as a tight-binding inhibitor of CD

22 ng trimetrexate and nitrobenzylmercaptpurine riboside 5' monophosphate.

23 riphosphate and 16-fold more potent than the riboside 5'-diphosphate.

24 ntains the substrate analogue 6-chloropurine riboside 5'-monophosphate (6-Cl-IMP) and the NAD analogu

25 cumulation of 5-aminoimidazole-4-carboxamide riboside 5'-monophosphate (ZMP), an intermediary of de n

26 constant for inactivation by 6-chloropurine riboside 5'-monophosphate is increased by 3-fold.

27 Interestingly, p-nitrophenyl riboside 5'-phosphate bound to OPRTs with Kd values near

28 ars ago, ZTP (5-aminoimidazole-4-carboxamide riboside 5'-triphosphate), a modified purine biosyntheti

29 )] and modified adenosine (2,6-diaminopurine riboside) 5'-triphosphates were incorporated into BRCA1

30 ymerase inhibitor, 5,6-dichlorobenzimidazole riboside (50 micromol/L), did not affect 1alpha, 25-(OH)

31 ouric acid (TU) and 2-amino-6-mercaptopurine riboside (6-TGR).

32 but the major product was 5'-chlorobenzamide riboside (7, 85%).

33 were inhibited by 5,6-dichlorobenzimidazole riboside, a drug that interferes with the addition of th

34 Nicotinamide riboside, a form of vitamin B3, protects against excitot

35 tant is able to catalyze hydration of purine riboside, a ground-state analog of the reaction.

36 sue, Belenky et al. report that nicotinamide riboside, a new NAD(+) precursor, regulates Sir2 deacety

37 velopment of steatosis in mice, nicotinamide riboside, a precursor of NAD(+) biosynthesis, was added

38 re of any of these mutants to hydrate purine riboside, a reaction carried out by the wild-type enzyme

39 nalogue, and (6S)-hydroxyl-1,6-dihydropurine riboside, a reaction coordinate analogue, have been dete

40 d by the oral administration of nicotinamide riboside, a recently discovered vitamin precursor of nic

41 SMC cultures with 5,6-dichlorobenzimidazole riboside, a selective inhibitor of RNA polymerase II, in

42 r study, 5-amino-imidazolecarboxamide (AICA) riboside, a stimulator of AMP kinase, significantly inhi

43 activation by 5-aminoimidazole-4-carboxamide riboside, A769662 or C13 attenuated Kv 1.5 currents in p

44 These ProTides, along with kinetin riboside, activated PINK1 in cells independent of mitoch

45 nosine analog 5-aminoimidazole-4-carboxamide riboside (AICAR) and inhibition by caffeine and Pfizer c

46 treated with 5-amino-4-imidazole carboxamide riboside (AICAR) for the detection of AMPK phosphorylati

47 by exogenous 5-amino-4-imidazolecarboxamide riboside (AICAr) in a AICAr and MTX concentration-depend

48 tor of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR) inhibited lipopolysaccharide (LPS)-indu

49 of AMPK using 5-aminoimidazole-4-carboxamide riboside (AICAR) inhibited O2-sensitive K+ currents (car

50 ble activator 5-aminoimidazole-4-carboximide riboside (AICAR) is associated with an increase in the o

51 on of AMPK by 5-amino-4-imidazolecarboxamide riboside (AICAR) leads to increased glucose transport.

52 with a pharmacological AMPK activator, AICA-riboside (AICAR) resulted in a time- and concentration-d

53 ative stress, 5-aminoimidazole-4-carboxamide riboside (AICAR), a pharmacological activator of AMPK, i

54 tor, 5-aminoimidazole-4-carboxamide-1-beta-d-riboside (AICAR), activated PYK2, ERK and aPKCs; (b) eff

55 ma cells with 5-aminoimidazole-4-carboxamide riboside (AICAR), an agent that activates AMP-activated

56 5-Aminoimidazole-4-carboxamide riboside (AICAR), an agent with diverse pharmacological

57 ug metformin, 5-aminoimidazole-4-carboxamide riboside (AICAR), and ischemia, well established trigger

58 imetic agent, 5-aminoimidazole-4-carboxamide riboside (AICAR), by the antidiabetic drug phenformin, o

59 tor of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR), inhibited oxidative stress-induced pho

60 K) activator, 5-aminoimidazole-4-carboxamide riboside (AICAR), on tumor necrosis factor alpha (TNF-al

61 MPK activator 5-aminoimidazole-4-carboxamide riboside (AICAR).

62 vation (using 5-aminoimidazole-4-carboxamide riboside [AICAR]) induces raptor phosphorylation and inh

63 oimidazole ribotide (AIR) and aminoimidazole riboside (AIr), the enzyme substrates that are predicted

64 to efficiently use exogenous aminoimidazole riboside (AIRs) as a source of thiamine.

65 and other aldoses) to give a mixture of four ribosides: alpha and beta pyranosides and furanosides.

66 nicotinamide mononucleotide and nicotinamide riboside also increases NAD(+) levels in astrocytes.

67 stration of 5-aminoimidazole-4-carboxamide-1-riboside also prevented renal hypertrophy, glomerular ba

68 AICA riboside also triggered GVB when meiotic arrest was main

69 NAD(+) repletion via nicotinamide riboside ameliorated disease phenotypes in SCA7 mice and

70 -4-carboxamide 1-beta-d-ribofuranoside (AICA riboside), an activator of AMPK, was tested on denuded o

71 -4-carboxamide-1-beta-D-ribofuranoside (AICA-riboside), an analog of adenosine, is taken up into cell

72 Conversely, 5-aminoimidizole-4-carboxamide riboside, an activator of AMPK, promotes transepithelial

73 at addition of 5-amino-imidazole carboxamide riboside, an AMPK activator, to WGA and human hepatocyte

74 activated by 5-aminoimidazole-4-carboxamide riboside, an AMPK agonist, these data indicate that RNS

75 supplementation of a diet with nicotinamide riboside, an NAD precursor, replenished hepatic NADP and

76 Using purine riboside analogues labeled with 15N1 or 13C6 and the the

77 onstrained 2',3'-epoxide derivatives in both riboside and (N)-methanocarba series 13 and 21, respecti

78 ereoselective synthesis of beta-nicotinamide riboside and a series of related amide, ester, and acid

79 K activators 5-amino-4-imidazole carboxamide riboside and A769662 suppressed MMP-9 expression in WT M

80 n by A769662, 5-aminoimidazole-4-carboxamide riboside and C13 and by intracellular dialysis from a pa

81 inhibitors such as 5,6-dichlorobenzimidazole riboside and camptothecin can substantially block VM-26-

82 uman cells, Nrk2 phosphorylates Nicotinamide Riboside and generates NAD+ through an alternative salva

83 Creatine riboside and NANA may be robust urinary clinical metabol

84 Here, we show that nicotinamide riboside and nicotinic acid riboside are authentic intra

85 Recently, we discovered that nicotinamide riboside and nicotinic acid riboside are biosynthetic pr

86 e responsible for production of nicotinamide riboside and nicotinic acid riboside in cells.

87 ators such as 5-aminoimidazole-4-carboxamide riboside and phenformin.

88 nown as Basis, a combination of nicotinamide riboside and pterostilbene) supplementation in 111 adult

89 specific for phosphorylation of nicotinamide riboside and the cancer drug tiazofurin.

90 lular NAD(+) was manipulated by nicotinamide riboside and the NAMPT inhibitor FK866.

91 dichloro-1-beta-D-ribofuranosylbenzimidazole riboside and trastuzumab, but not between inhibitors of

92 the presence of aminoimidazole-4-carboxamide riboside and/or after alpha1AMP-activated protein kinase

93 ated levels of certain purine and pyrimidine ribosides and cytokinins that reflect the substrate pref

94 chloro-1-beta-D-riborfuranosyl benzimidazole riboside) and TCRB (2,5,6-trichloro-1-beta-D-riborfurano

95 ntation with the NAD precursor, nicotinamide riboside, and CD38 inhibition improved NAD homeostasis,

96 o-inositol and IAA-glucan, but not by zeatin riboside, and only weakly by gibberellic acid, abscisic

97 els of nicotinamide riboside, nicotinic acid riboside, and other NAD(+) metabolites were determined b

98 ethylnicotinate riboside, O-methylnicotinate riboside, and several N-alkyl derivatives increased NAD+

99 cis-Zeatin, cis-zeatin riboside, and their O-glucosides were detected in all ma

100 tors such as 5-amino-imidazole-4-carboxamide riboside, antimycin A, and sodium azide inhibited cell g

101 hat nicotinamide riboside and nicotinic acid riboside are authentic intracellular metabolites in yeas

102 hat nicotinamide riboside and nicotinic acid riboside are biosynthetic precursors of NAD(+), which ar

103 nicotinamide mononucleotide and nicotinamide riboside are reported to confer resistance to metabolic

104 n, we identified the plant cytokinin kinetin riboside as an inhibitor of CCND2 trans-activation.

105 ts reaction with adenosine generated kinetin riboside, as confirmed by comparing the MS/MS profiles o

106 A stem-loop RNA with p-nitrophenyl O-riboside at the depurination site is not a substrate, bu

107 ichloro-1-beta-d-ribofuranosyl benzimidazole riboside (BDCRB) was used to allow the accumulation of h

108 ichloro-1-beta-d-ribofuranosyl benzimidazole riboside (BDCRB) were characterized by nanoparticle trac

109 ichloro-1-beta-d-ribofuranosyl benzimidazole riboside (BDCRB)-treated cultures and purified by tangen

110 A member of the family of L-riboside benzimidazole compounds, 1263W94, was shown rec

111 The nicotinamide riboside binding site overlaps that of the substrate gal

112 mide riboside kinase and that nicotinic acid riboside bioavailability is increased by ester modificat

113 kinase 2 inhibitor 5,6-dichlorobenzimidazole riboside but not, however, by the PI3K inhibitor wortman

114 rd growth conditions, Nrt1, the nicotinamide riboside carrier, is the major AICAr transporter in yeas

115 g actinomycin D or 5,6-dichlorobenzimidazole riboside collagen alpha1(I) mRNA has estimated half-live

116 tions produce predominantly the beta-methoxy riboside compound, with a relative nucleophilicity of Me

117 Benzimidazole riboside compounds represent a new class of antiviral co

118 Nicotinamide riboside corrects social deficits and fearful and anxiet

119 e activation by aminoimidazole-4-carboxamide riboside counteracted lipopolysaccharide-induced hyperpe

120 2,6-Diaminopurine-riboside (DAP), 7-deazaguanosine (7-deaza-G), and 7-meth

121 rates, the MtCobT product 5-OHBza-RP and its riboside derivative 5-OHBza-R.

122 Among 9-riboside derivatives, only N(6)-cyclopentyl and 7-norbor

123 growth factor beta, or dichlorobenzimidazole riboside did not result in significant increases in spon

124 he CKII inhibitor, 5,6-dichlorobenzimidazole riboside, did not affect etoposide-stabilized topo II-DN

125 y actinomycin D or 5,6-dichlorobenzimidazole riboside (DRB) causes VHL to be redistributed to the nuc

126 y actinomycin D or 5,6-dichlorobenzimidazole riboside (DRB).

127 nistration of the NAD precursor nicotinamide riboside during pregnancy prevents the majority of in ut

128 Nicotinamide riboside efficiently rescues NAD(+) synthesis in respons

129 lorie restriction in the mouse, nicotinamide riboside elevates NAD(+) and increases Sir2 function.

130 Nicotinamide riboside elevates NAD+ levels via the nicotinamide ribos

131 phenformin or 5-aminoimidazole-4-carboxamide-riboside elicited discrete Ca2+ signaling mechanisms in

132 the Golgi, because 5,6-dichlorobenzimidazole riboside, emetine, and brefeldin A inhibited the increas

133 azido substitution at 3'-OH of nicotinamide riboside enables enzymatic synthesis of an NAD(+) analog

134 rthermore, supplementation with nicotinamide riboside enhanced T cell mitochondrial fitness and impro

135 lementation of yeast cells with nicotinamide riboside extends replicative lifespan and increases Sir2

136 inhibitor platform 5-(formylamino)imidazole riboside (FAIRs, 4) was designed by removal of the-C6(OH

137 Incorporation of the C-riboside formycin A at the depurination site provides an

138 ic base pair analogs (inosine, diaminopurine riboside, guanosine, or adenosine paired with U, C, or i

139 imetic AICAR (5-aminoimidazole-4-carboxamide riboside) has been shown to inhibit hepatic gluconeogene

140 se is 100-fold more active as a nicotinamide riboside hydrolase than as a uridine hydrolase and that

141 Hst1, and Rfm1, fully restores nicotinamide riboside import and utilization when resupplied to mutan

142 of nicotinamide riboside and nicotinic acid riboside in cells.

143 Meiotic induction by AICA riboside in dbcAMP-supplemented medium was initiated wit

144 of AMPK by 5-aminoimidazole-4-carboxamide-1-riboside in OVE26 mice attenuated Nox4 and p53 expressio

145 uptake observed with AMPK activation by AICA-riboside in perfused rat hindlimb muscles is due to an i

146 ue formation of a C-riboside instead of an N-riboside in the condensation of p-aminobenzoic acid (pAB

147 mmation and question the use of nicotinamide riboside in the therapy of inflammatory disorders.

148 n does not cause a decrease in the CK zeatin riboside in the xylem sap or a strong increase in RMS1 t

149 nistration of 5-aminoimidazole-4-carboxamide riboside in Vasp(-/-) mice reduced hepatic steatosis and

150 Nrk-independent utilization of nicotinamide riboside in yeast.

151 8-nitro-1,2,3,4-tetrahydroisoquinolylpurine ribosides, in which the nitrobenzyl moiety in NBMPR has

152 MPK activator 5-aminoimidazole-4-carboxamide-riboside increased AMPK activity twofold and completely

153 nicotinamide mononucleotide or nicotinamide riboside increases total NAD(+) content in ALS astrocyte

154 Kinetin riboside induced marked suppression of CCND2 transcripti

155 axon (0.1 mm 5-aminoimidazole-4-carboxamide riboside) induced a depression of the mean frequency, ve

156 Similarly, purine riboside inhibitors of ADA that prefer the N hemisphere

157 ngdom; one preferentially targets the purine ribosides inosine and xanthosine, while the other is mor

158 nthase catalyzes the unique formation of a C-riboside instead of an N-riboside in the condensation of

159 e cytokinin [N6-(Delta2 isopentenyl) adenine riboside] (iPR).

160 In eukaryotes, nicotinamide riboside is a newly discovered NAD(+) precursor that is

161 Nicotinamide riboside is a recently discovered eukaryotic NAD(+) prec

162 trient in milk, suggesting that nicotinamide riboside is a useful compound for elevation of NAD+ leve

163 xperimentally and revealed that nicotinamide riboside is an unanticipated NAD+ precursor in yeast.

164 uptake observed with AMPK activation by AICA-riboside is due to GLUT4 translocation from an intracell

165 shown that exogenously supplied nicotinamide riboside is imported into yeast cells by a dedicated tra

166 e reaction and a C-riboside rather than an N-riboside is the product.

167 The mechanism of action of nicotinamide riboside is totally dependent on increased net NAD(+) sy

168 Creatine riboside (IUPAC name: 2-{2-[(2R,3R,4S,5R)-3,4-dihydroxy-

169 Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting

170 tinamide precursor, whereas the nicotinamide riboside kinase 2 (NMRK2) that phosphorylates the nicoti

171 We found that Nicotinamide riboside kinase 2b (Nrk2b) cell autonomously modulates t

172 We find that nicotinamide riboside kinase 2b-mediated NAD+ biosynthesis, which fun

173 epends on uridine hydrolase and nicotinamide riboside kinase and that nicotinic acid riboside bioavai

174 de elevates NAD+ levels via the nicotinamide riboside kinase pathway and by a pathway initiated by sp

175 sor converted to NAD(+) via the nicotinamide riboside kinase pathway and by nucleosidase activity and

176 se is responsible for mammalian nicotinamide riboside kinase-independent nicotinamide riboside utiliz

177 Nicotinamide riboside kinases from yeast and humans essential for thi

178 mide mononucleotide by specific nicotinamide riboside kinases, Nrk1 and Nrk2.

179 We characterized a single compound, kinetin riboside (KR), on AML L-ICs and HSPCs.

180 s with apigenin or 5,6-dichlorobenzimidazole riboside led to a rapid decrease in NKX3.1 accumulation

181 that elevating NAD levels with nicotinamide riboside may allow animals with cADPR- and OT-forming de

182 cause current data suggest that nicotinamide riboside may be the only vitamin precursor that supports

183 alidate MtBzaC as a SAM:hydroxybenzimidazole-riboside methyltransferase (HBIR-OMT).

184 The adenosine moiety and the nicotinamide riboside moiety are both in the anti conformation about

185 The anti conformation of the nicotinamide riboside moiety is in accord with the preferred conforma

186 of activity, suggesting that the nicotinate riboside moiety is recognized as a neutral zwitterion.

187 ion by NAIM using 5'-O-(1-thio)diaminopurine riboside monophosphate (DMP alphaS), an adenosine analog

188 p into cells and phosphorylated to form AICA-riboside monophosphate (ZMP), which can also activate AM

189 evels of trans-zeatin riboside, trans-zeatin riboside monophosphate and isopentenyladenine 9-glucosid

190 icotinamide riboside (NR) and nicotinic acid riboside (NAR) are the major precursors for NAD biosynth

191 reased the S6-(4-nitrobenzyl)-mercaptopurine riboside (NBMPR) IC50 values by approximately 4- and 6-f

192 the ENT1 inhibitor nitrobenzylmercaptopurine riboside (NBMPR) in intact cells.

193 th antifolates and nitrobenzylmercaptopurine riboside (NBMPR), a potent inhibitor of the es nucleosid

194 ransporter ligand, nitrobenzylmercaptopurine riboside (NBMPR), designed for probing its bound (bioact

195 cDNA encoding the nitrobenzylmercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside t

196 osine uptake using nitrobenzylmercaptopurine riboside (NBMPR).

197 ype ENT1 inhibitor nitrobenzylmercaptopurine riboside (NBMPR).

198 he simultaneous quantitation of nicotinamide riboside, nicotinamide mononucleotide and NAD in milk by

199 ay, and intracellular levels of nicotinamide riboside, nicotinic acid riboside, and other NAD(+) meta

200 Nicotinamide riboside, nicotinic acid riboside, O-ethylnicotinate rib

201 Administration of nicotinamide riboside (NmR) has been shown to ameliorate deficiencies

202 Nicotinamide riboside (NmR) is a key pyridine metabolite that is excr

203 cotinic acid, nicotinamide, and nicotinamide riboside (NmR), via multiple enzymatic steps.

204 In this study, we explored whether the ribosides NR and NAR can be generated in human cells.

205 d prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD.

206 Addition of NA or nicotinamide riboside (NR) allows a moved mother to maintain replicat

207 entation with the NAD-precursor nicotinamide riboside (NR) ameliorates energetic derangement and symp

208 as stimulated investigations of nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).

209 e and nicotinic acid as well as nicotinamide riboside (NR) and nicotinic acid riboside (NAR) are the

210 inucleotide (NAD(+) ) precursor nicotinamide riboside (NR) boosts NAD(+) levels and improves diseases

211 ion with NAD precursors such as nicotinamide riboside (NR) has been shown to enhance mitochondrial fu

212 The activity of nicotinamide riboside (NR) in neuroprotective models and the recent d

213 namide mononucleotide (NMN) and nicotinamide riboside (NR) in the amidated salvage pathway despite no

214 Nicotinamide riboside (NR) is a newly discovered nicotinamide adenine

215 Nicotinamide riboside (NR) is an endogenously produced key pyridine m

216 Nicotinamide riboside (NR) is an NAD+ precursor that boosts cellular

217 Nicotinamide riboside (NR) is in wide use as an NAD(+) precursor vita

218 lly, deletion of SSY5 increases nicotinamide riboside (NR) levels and phosphate-responsive (PHO) sign

219 ation with the NAD(+) precursor nicotinamide riboside (NR) markedly reprograms metabolic and stress-r

220 l trial to report on effects of nicotinamide riboside (NR) on skeletal muscle mitochondrial function,

221 Restoring NAD(+) pools with nicotinamide riboside (NR) prevents DNA damage and tumor formation.

222 Acute nicotinamide riboside (NR) supplementation does not alter substrate m

223 The gene for the nicotinamide riboside (NR) transporter (pnuC) was identified in Haemo

224 fter taking 5 to 9 days of oral nicotinamide riboside (NR), a NAD precursor.RESULTSWe demonstrated th

225 liver regeneration, we supplied nicotinamide riboside (NR), an NAD precursor, in the drinking water o

226 ounds, including NAD+ precursor nicotinamide riboside (NR), confer antiinflammatory effects.

227 inamide mononucleotide (NMN) or nicotinamide riboside (NR), protects against metabolic disease, neuro

228 sis from nicotinamide (NAM) and nicotinamide riboside (NR), while down-regulating other NAD biosynthe

229 id (NA), nicotinamide (NAM) and nicotinamide riboside (NR).

230 icotinamide, nicotinic acid, or nicotinamide riboside (NR).

231 we describe synthesis of dihydronicotinamide riboside (NRH) and the discovery that NRH is a potent NA

232 Dihydronicotinamide riboside (NRH):quinone oxidoreductase 2 (NQO2) is a flav

233 Nicotinamide riboside, nicotinic acid riboside, O-ethylnicotinate riboside, O-methylnicotinate

234 , nicotinic acid riboside, O-ethylnicotinate riboside, O-methylnicotinate riboside, and several N-alk

235 he trans isomer, although cis-zeatin and its riboside occur as major components in some plant species

236 ent facilitator with a K(m) for nicotinamide riboside of 22 microm.

237 fects of the sirtuin activator, nicotinamide riboside, on NLRP3 inflammasome activation.

238 ocytes, 8 mmol/l glucose, and +/-2 mmol/AICA-riboside or +/-60 nmol/l insulin.

239 of AMPK with 5-aminoimidazole-4-carboxamide riboside or salicylate increased nNOS S1412 phosphorylat

240 nine dinucleotide (NAD(+)) with nicotinamide riboside partially blocked neurodegeneration, and increa

241 Furthermore, 5-aminoimidizole-4-carboxamide riboside partially protects the tight junctions from dis

242 t the synthesis of a novel 2'-O-methyl (OMe) riboside phosphoramidite derivative of the G-clamp tricy

243 cue of 8-azaadenosine (pK(a) 2.2) and purine riboside (pK(a) 2.1) interference at A756 at reduced rea

244 y of nucleoside analogs [inosine (I), purine riboside (PR), 2-aminopurine (2-AP), 2,6-diaminopurine (

245 (NMRK2) that phosphorylates the nicotinamide riboside precursor is increased, to a higher level in th

246 ater presented mainly cytokinin trans-zeatin riboside, procyanidin dimer, caffeoylshikimic acid and t

247 tinic acid mononucleotide and nicotinic acid riboside production are also uncovered that further unde

248 y, we discovered that exogenous nicotinamide riboside promotes Sir2-dependent repression of recombina

249 um stability, and hydrolysis of four kinetin riboside ProTides.

250 P450 reductase (P450R), dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2), and xanthine o

251 xidoreductase (NQO1) and dihydronicotinamide riboside:quinone oxidoreductases (NQO2) are cytosolic fl

252 tes (pAB) occurs during the reaction and a C-riboside rather than an N-riboside is the product.

253 sing the inhibitor nitrobenzylmercaptopurine riboside recapitulated the RBV-resistant phenotype in RB

254 subjected to pressure overload, nicotinamide riboside reduced cardiomyocyte death and contractile dys

255 ewly identified NAD+ precursor, nicotinamide riboside, reviewed herein, are responsible for vitamin-s

256 Additionally, the two nicotinamide riboside salvage pathways contribute to NAD(+) metabolis

257 rba (i.e., of the Northern conformation) and riboside series 18 and 5, respectively, were potent anta

258 groups that enhance A(3)AR affinity in the 9-riboside series, including those that reduce intrinsic e

259 The 5-aminoimidazole-4-carboxamide riboside served to study the impact of AMP-activated pro

260 Supplementation of NAD(+) with nicotinamide riboside slowed the axon degeneration and demyelination,

261 Degradation of natural nucleic acid ribosides, such as ATP, using periodate oxidation simpli

262 we present prospects for human nicotinamide riboside supplementation and propose areas for future re

263 Accordingly, we show that nicotinamide riboside supplementation in food attenuates the developm

264 Nicotinamide riboside supplementation of yeast extends replicative li

265 +) metabolism in the absence of nicotinamide-riboside supplementation.

266 Zebularine is a riboside that must undergo a complex metabolic transform

267 and absence of trans-zeatin and trans-zeatin riboside (the most active cytokinins) in TMB-treated see

268 The data show that nicotinamide riboside, the most energy-efficient among NAD precursors

269 Nicotinamide riboside, the most recently discovered form of vitamin B

270 The ability of nicotinamide riboside to enhance life span does not depend on calorie

271 ice, we demonstrate that the cleavage of the riboside to Nam is strongly diminished, maintaining high

272 growth factor beta, or dichlorobenzimidazole riboside to the medium.

273 ts accumulated higher levels of trans-zeatin riboside, trans-zeatin riboside monophosphate and isopen

274 9-Ribosides transformed into the ring-constrained (N)-meth

275 Nicotinamide riboside treatment also robustly increases the myocardia

276 t observed by 5-aminoimidazole-4-carboxamide riboside treatment.

277 Mechanistically, kinetin riboside upregulated expression of transcription repress

278 The molecular basis for nicotinamide riboside uptake was unknown in any eukaryote.

279 single gene, YOR071C, abrogates nicotinamide riboside uptake without altering nicotinic acid or nicot

280 suggesting a similar basis for nicotinamide riboside uptake.

281 -1r was prepared from 2-amino-6-chloropurine riboside using adenosine deaminase.

282 Finally, we show that yeast nicotinic acid riboside utilization largely depends on uridine hydrolas

283 ide riboside kinase-independent nicotinamide riboside utilization.

284 Secreted nicotinamide riboside was detected with a biological assay, and intra

285 Nicotinamide riboside was discovered as a nutrient in milk, suggestin

286 Perfusion medium containing AICA-riboside was found to significantly increase AMPK activi

287 Creatine riboside was the strongest classifier of lung cancer sta

288 Smaller and variable amounts of trans-zeatin riboside were also recovered.

289 at P2Y(1) receptors, while the corresponding ribosides were inactive.

290 0]bicyclohexyl) adenosines and corresponding ribosides were synthesized to identify novel A(1) adenos

291 chloro-1-beta-D-riborfuranosyl benzimidazole riboside) were the first compounds shown to inhibit clea

292 cleoside phosphorylase cleave nicotinic acid riboside, whereas the yeast phosphorylase has little act

293 fect the bovine milk content of nicotinamide riboside, whereas UHT processing fully destroyed the vit

294 Boosting the UPR(mt) with nicotinamide riboside (which augments NAD(+) pools) in cardiomyocytes

295 s blocked by 5-amino imidazole-4-carboxamide riboside (which is converted to an AMP-mimetic) or the p

296 ) confers high hydrolase activity for purine ribosides, while an aspartate residue in this position c

297 s also shown to synthesize 2,6-diaminopurine riboside with a catalytic efficiency (1.4 x 10(6) M-1 s-

298 Maribavir is a benzimidazole riboside with activity against cytomegalovirus (CMV).

299 Maribavir is an oral benzimidazole riboside with potent in vitro activity against cytomegal

300 larity of the complex with the dihydropurine riboside with that of an identical complex previously de